Results 61 to 70 of about 20,271 (243)

Study of Clinical Characteristics of Desquamative Gingivitis in 60 Patients in the North of Spain

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Objectives The aim of this study is to know the clinical characteristics of desquamative gingivitis (DG) in a Spanish population in order to make an early diagnosis of this sign and, therefore, the underlying systemic disease. Methods A cross‐sectional study was conducted.
Valeria Sanmartín‐Barragáns   +7 more
wiley   +1 more source

Coexistence of lupus vulgaris and scrofuloderma in an immunocompetent patient: A rare presentation

open access: yesClinical Dermatology Review, 2023
Tuberculosis (TB) may involve cutaneous tissue in approximately 0.1%–0.5% of the cases. There are various morphological presentations of cutaneous TB such as lupus vulgaris (LV), scrofuloderma, TB verrucosa cutis, and tuberculids.
Navneet Kaur   +3 more
doaj   +1 more source

گزارش يک مورد تظاهر غيرمعمول سل جلدی [PDF]

open access: yes, 2007
مقدمه: با توجه به ظهور مجدد سل در جهان، سل جلدی نيز از مشکلات تشخيصی و بالينی باقی‌مانده است. لوپوس ولگاريس، شايع‌ترين نوع سل جلدی می‌باشد. معرفی بيمار: بيمار، آقای 35 ساله‌ای بود که با ضايعات متعدد پوستی در صورت و گردن از سالها پيش مراجعه نموده بود. قبل
تکليف, ماه جبین   +1 more
core  

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

The metabolomics of psoriatic disease. [PDF]

open access: yes, 2017
Metabolomics is an emerging new "omics" field involving the systematic analysis of the metabolites in a biologic system. These metabolites provide a molecular snapshot of cellular activity and are thus important for understanding the functional changes ...
Afifi, Ladan   +6 more
core  

Diagnostic Delay in Desquamative Gingivitis: An Observational Cohort Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Non‐plaque‐induced gingivitis encompasses a heterogeneous group of conditions as defined in the 2017 Classification of Periodontal and Peri‐Implant Diseases and Conditions. Recognition is challenging and often leads to diagnostic delay.
Alessandra Caggiula   +5 more
wiley   +1 more source

Cutaneous tuberculosis and squamous-cell carcinoma Tuberculose cutânea e carcinoma de células escamosas

open access: yesAnais Brasileiros de Dermatologia, 2011
The incidence of all forms of cutaneous tuberculosis, including lupus vulgaris (the most common form) decreased progressively in developed countries during the twentieth century, this change being attributed to improved living standards and specific ...
Milanka S Ljubenovic   +4 more
doaj   +1 more source

Lots of autoantibodies equal lupus? [PDF]

open access: yes, 2013
Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For systemic lupus erythematosus (SLE), those to RNA-binding proteins, to phospholipids, and to double-stranded DNA, in particular, have been found in sera of SLE
Aringer, M, Vital, E
core   +1 more source

Unusual Sites of Cutaneous Tuberculosis: A Report of Two Cases

open access: yesCase Reports in Dermatological Medicine, 2017
Cutaneous tuberculosis (CTB) is an uncommon small subset of extrapulmonary tuberculosis, comprising 1–1.5% of all extrapulmonary tuberculosis manifestations, which manifests only in 8.4–13.7% of all tuberculosis cases.
Dimple Chopra   +5 more
doaj   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

open access: yesMedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source

Home - About - Disclaimer - Privacy